ROSS ROBERT W. 4
4 · Xilio Therapeutics, Inc. · Filed Jun 17, 2022
Insider Transaction Report
Form 4
ROSS ROBERT W.
Director
Transactions
- Award
Stock Option (right to buy)
2022-06-15+26,400→ 26,400 totalExercise: $2.28Exp: 2032-06-14→ Common Stock (26,400 underlying)
Footnotes (1)
- [F1]The option award was granted on June 15, 2022 and will vest in three equal installments on June 15, 2023, June 15, 2024 and June 15, 2025.